Monte Rosa Therapeutics announced data for MRT-8102, its NEK7-directed molecular glue degrader, showing positive impact on biomarkers linked to atherosclerotic cardiovascular disease
BiotechTV - News
00:00
Calprotectin and HMGB1 Support Translational Evidence
Markus Warmuth highlights calprotectin, HMGB1, IL-1 beta, and other biomarkers as evidence that MRT-8102 broadly suppresses inflammatory drivers.
Play episode from 11:28
Transcript
